Pluristem Therapeutics Awarded a $3.3 Million Grant by Israeli Government

Published: Aug 06, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

HAIFA, Israel, Aug. 6, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR) today announced that its wholly owned subsidiary, Pluristem Ltd., has received approval for a 12 million New Israeli Shekels (approximately $3.3 million) grant from the Office of the Chief Scientist (OCS) within the Israeli Ministry of Economy. Once received, the grant will be used to cover R&D expenses for the period January 2013 to December 2013.

Help employers find you! Check out all the jobs and post your resume.

Back to news